LifeArc announces strategic partnership with PrecisionLife as part of its Motor Neuron Disease Translational Challenge

LifeArc and PrecisionLife will work together to select and validate multiple novel targets and their accompanying patient stratification biomarkers.

Meet our industrial placement students – class of 2023

Find out what this year's cohort of industrial placement students gained from the experience.

LifeArc & Cystic Fibrosis Trust announce new £15m research funding to fast track treatment of lung infections

Focussing on innovative approaches to improve quality of life for people with cystic fibrosis (CF)

Translational research into children’s rare diseases enters 5th year of collaborative funding

To accelerate research that will have a significant impact on the treatment of children and young people.

Dr Jason Slingsby joins LifeArc as Chief Business Officer

Jason will be responsible for developing, leading, and implementing LifeArc’s business development and partnering strategies.

LifeArc launches £40m funding call to create Translational Rare Disease Centres

Centres to become focal points for rare disease research translation and engagement with the patient community across the UK.

LifeArc plans two major funding calls to boost translational research in rare disease & lung health in cystic fibrosis

The calls are part of our wider £100m programme to support scientific innovation for people living with cystic fibrosis.

Talking to FLIER future leaders about learning from COVID-19 and the power of collaboration

The Future Leaders in Innovation Enterprise and Research is a two-year programme for emerging leaders in science, technology and medicine.

LifeArc joins the Campaign for Science and Engineering

Network of over 115 members works to put research at the heart of the UK’s future.